Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LYEL compared with VIR: revenue, margins and what each company keeps, and the suppliers and customers both name
LYEL
Lyell Immunopharma, Inc.
Change
Mkt cap
Revenue
Revenue
VIR
Vir Biotechnology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LYEL
Lyell Immunopharma, Inc.
vs
VIR
Vir Biotechnology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LYEL, solid
VIR, dashed
LYEL
Lyell Immunopharma, Inc.
Change
10.79
▼
−0.86%
· post 10.79
· delayed
Mkt cap
$266.6M
Revenue
$4,000
Q2 FY26
Revenue
$36,000
FY25
VIR
Vir Biotechnology, Inc.
Change
11.22
▲
+2.00%
· post 11.22
· delayed
After hours
Nov 3 '26
delayed
Mkt cap
$1.9B
Revenue
$239M
Q2 FY26
Revenue
$74M
FY24
vs
Compare
After hours
Nov 3 '26
delayed
LYEL
Lyell Immunopharma, Inc.
vs
VIR
Vir Biotechnology, Inc.
10.79
▼
−0.86%
post 10.79
delayed
Price
11.22
▲
+2.00%
post 11.22
delayed
$266.6M
Mkt cap
$1.9B
Q2 FY26
$4,000
Revenue
$239M
Q2 FY26
FY25
$36,000
Revenue
$74M
FY24
Change
Change
LYEL
10.79
▼
−0.86%
vs
VIR
11.22
▲
+2.00%
After hours
Nov 3 '26
delayed